306 filings
8-K
NRIX
Nurix Therapeutics Inc
12 Apr 24
Nurix Therapeutics Announces Pricing of Upsized $175.0 Million Public Offering
5:12pm
424B5
NRIX
Nurix Therapeutics Inc
12 Apr 24
Prospectus supplement for primary offering
5:10pm
424B5
NRIX
Nurix Therapeutics Inc
11 Apr 24
Prospectus supplement for primary offering
4:06pm
10-Q
2024 Q1
NRIX
Nurix Therapeutics Inc
Quarterly report
10 Apr 24
7:06am
8-K
NRIX
Nurix Therapeutics Inc
10 Apr 24
Nurix Therapeutics Reports First Quarter Fiscal 2024 Financial Results and Provides a Corporate Update
7:02am
8-K
2z4h40 9yic
9 Apr 24
Other Events
1:17pm
ARS
7a9em3
27 Mar 24
Annual report to shareholders
7:03am
DEFA14A
swwhhxjb
27 Mar 24
Additional proxy soliciting materials
7:02am
8-K
6lssg xuqtb
11 Mar 24
Nurix Therapeutics Announces U.S. FDA Lifts Partial Clinical Hold on NX-2127 Phase 1 Trial
7:02am
4
dcc6dvkykaxm
16 Feb 24
Nurix Therapeutics / Houte Hans van ownership change
7:20pm
144
tg5pwvn
16 Feb 24
Notice of proposed sale of securities
4:22pm
S-8
vf3pnwwxp749pu
15 Feb 24
Registration of securities for employees
4:51pm
8-K
nto3 gpdk8
15 Feb 24
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Provides a Corporate Update
4:01pm
4
pa3wqv4q7ekrxm9kek
15 Feb 24
Nurix Therapeutics / Houte Hans van ownership change
7:23am
4
qlgxju
15 Feb 24
Nurix Therapeutics / Christine Ring ownership change
7:23am
4
mhwsbckh737ry37s1
15 Feb 24
Nurix Therapeutics / Gwenn Hansen ownership change
7:23am
4
ws81w6ueqse
15 Feb 24
Nurix Therapeutics / ARTHUR T SANDS ownership change
7:22am
SC 13G/A
e9g4z
14 Feb 24
Nurix Therapeutics / Redmile ownership change
4:26pm